Article Text
Abstract
The introduction of new sequencing technologies whole-genome sequencing (WGS) and whole-exome sequencing (WES) that are much less finely targeted than previous genetic tests has resulted in ethical debate about what should be done with clinically significant findings that may arise during the sequencing process. In this piece we argue that, in addition to whether the finding has been intentionally sought or arises incidentally, the ethical issues concerning what should be done with WES and WGS findings are also influenced by whether sequencing occurs in a clinical or research setting. We argue that decisions about the disclosure of WGS and WES findings generated in the clinical context are much less ethically contentious than decision making about the feedback of research results. We conclude by calling for greater transparency about the purpose of sample collection, more explicit protocols for transitioning between research and clinical contexts and patients and research participants to be warned of the potential for incidental findings to be generated, their potential significance and the actions that might be taken as a result.
- Genethics
- Genetic Information
- Genetic Screening/Testing
- Clinical Ethics
- Research Ethics
Statistics from Altmetric.com
Linked Articles
- Genetics
- Genetics
- Genetics
- The concise argument
Other content recommended for you
- Guideline for feedback of individual genetic research findings for genomics research in Africa
- Taking it to the bank: the ethical management of individual findings arising in secondary research
- Should institutions fund the feedback of individual findings in genomic research?
- Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy
- Singapore Undiagnosed Disease Program: Genomic Analysis aids Diagnosis and Clinical Management
- Exome sequencing as a first-tier test for copy number variant detection: retrospective evaluation and prospective screening in 2418 cases
- Whole-genome sequencing
- The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists
- Modern genomic techniques in the identification of genetic causes of cardiomyopathy
- Rare MYC-N11S germline mutation indicative of inherited breast cancer in a multigeneration family